We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Loss of p53 Promotes Survival of Cancer Stem Cells

By LabMedica International staff writers
Posted on 26 Oct 2017
Print article
Image: If mitophagy or Pac Man eats all the cell\'s mitochondria, then the \"seeds of cancer\" (stem cells) will be able to grow unhindered and develop more malignant tumors (Photo courtesy of the University of Southern California, Keck School of Medicine / Linya Wang).
Image: If mitophagy or Pac Man eats all the cell\'s mitochondria, then the \"seeds of cancer\" (stem cells) will be able to grow unhindered and develop more malignant tumors (Photo courtesy of the University of Southern California, Keck School of Medicine / Linya Wang).
Cancer researchers have found that the cellular cleansing process known as mitophagy is linked to the development and progression of liver cancer.

Mitophagy is the selective degradation of mitochondria by autophagy. It often occurs to defective mitochondria following damage or stress. In addition to the selective removal of damaged mitochondria, mitophagy is also required to adjust mitochondrial numbers to changing cellular metabolic needs, for steady-state mitochondrial turnover, and during certain cellular developmental stages, such as during cellular differentiation of red blood cells.

Investigators at the University of Southern California (Los Angeles, USA) reported in the October 12, 2017, online edition of the journal Molecular Cell that mitophagy promoted the maintenance of hepatic cancer stem cells (CSCs) through the loss of the tumor suppressor protein p53, which was closely associated with the mitochondria.

When mitophagy was inhibited, the p53 protein on mitochondria was phosphorylated at serine-392 by the enzyme PINK1, a kinase associated with mitophagy. The phosphorylated p53 was then translocated into the nucleus, where it bound to the NANOG promoter. This binding prevented the OCT4 and SOX2 transcription factors from activating the expression of NANOG, a transcription factor critical for maintaining the stem cell properties and the self-renewal ability of CSCs, resulting in the reduction of hepatic CSC populations.

"Liver cancer is difficult to treat, and most patients who are diagnosed with it will die within a five-year period," said senior author Dr. Jing-Hsiung James Ou, professor of molecular microbiology and immunology at the University of Southern California. "My team has identified how liver cancer stem cells are maintained. Without these "seeds of cancer," liver tumors would shrink and eventually disappear. Now that we understand the molecular process, we will be able to target this pathway to stop the production of cancer stem cells. If cancer stem cells are gone, cancer is gone."

Related Links:
University of Southern California

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more